ALVOTECH
Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab). Alvotech will vigorously defend against these allegations.
Notably, AbbVie waited over three years from the purported date of the alleged wrongdoing to file its case, doing so after the ex-AbbVie employee had already left Alvotech and without naming the ex-AbbVie employee as a defendant.
This lack of urgency causes Alvotech to question the motivation behind the case. Indeed, Alvotech believes that the case may be part of a larger AbbVie strategy to delay an emerging competitor from providing patients with a lower-cost alternative to AbbVie’s HUMIRA® high-concentration product.
Alvotech will continue its efforts to increase accessibility to high quality and affordable medicines.
About Alvotech:
Alvotech is a multinational biopharmaceutical company focused on the development and manufacture of high quality biosimilars for global markets. We are specialists in biotechnology, seeking to be a global leader in the biosimilar space by delivering high quality, cost-competitive products and services to our partners and to patients worldwide. Our fully integrated approach, with high-quality in-house competencies throughout the value chain, enables the accelerated development of biosimilar products. Alvotech’s shareholder base includes, among others, Aztiq Pharma, led by founder and Chairman Mr. Robert Wessman, Cipla Gulf FZ from Australia and New Zeland, Shinhan from Korea, Baxter Healthcare SA, YAS Holdings, ATHOS (Strüngmann Family Office), CVC Capital Partners and Temasek from Singapore.
Alvotech‘s initial pipeline contains several monoclonal-antibody and fusion-protein biosimilar candidates aimed at treating autoimmunity, oncology and inflammatory conditions to improve quality of life for patients around the world. For more information, please visit our website, www.alvotech.com or follow us on LinkedIn , Twitter and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005659/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hercle Raises $60M to Scale Institutional-Grade Infrastructure for Global Money Movement29.10.2025 13:30:00 CET | Press release
Round includes $10 million in equity, led by F-Prime, and a $50M credit facility to support global expansionSince launch, Hercle’s platform has processed over $20B in transactions, settling multi-million cross-border flows in stablecoins, digital assets, and fiat within minutes Hercle, an institutional infrastructure platform bridging stablecoins, digital assets, and cross-border settlement, today announced $60 million in new capital. The round features a $10 million equity investment led by F-Prime, with participation from Fulgur Ventures and Exponential Science, alongside a $50 million credit line to support the expansion of institutional services and global growth initiatives. To date, Hercle’s platform has processed more than $20 billion in transactions, enabling global institutions to move millions of dollars across borders and digital assets in minutes. Hercle was built to bridge a critical infrastructure gap in the evolving stablecoin and digital asset ecosystem. As institutions
Veracode Report Finds 63% of Financial Services Firms Carry Critical Security Debt, Heightening Supply Chain Risk29.10.2025 12:50:00 CET | Press release
Open-source Vulnerabilities Account for 82% of Critical Security Debt Across Banking, Financial Services, and Insurance Organizations Veracode, the global leader in application risk management, today released its 2025 State of Software Security (SoSS) Snapshot for the Financial Services Sector. The analysis reveals nearly two-thirds (63 percent) of banking, financial services, and insurance (BFSI) organizations harbor critical security debt—high-severity flaws left unfixed for longer than a year—a rate of 13 percentage points higher than the cross-industry average. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029207424/en/ Fig. 1: Financial service sector flaw remediation timeline based on survival analysis "Trust is everything in financial services, yet our data reveals a silent, growing risk for the sector created by unresolved security debt," said Chris Wysopal, Co-founder & Chief Security Evangelist at Veracode. "Wi
NuORDER by Lightspeed Extends Partnership with Nordstrom as Retailer Invests in Data-Driven Wholesale Strategies29.10.2025 12:05:00 CET | Press release
NuORDER by Lightspeed, a leading global commerce platform that enables retailers and brands to connect, collaborate, and make smarter buying decisions, today announced Nordstrom is strengthening its partnership with NuORDER by Lightspeed. NuORDER will play a larger role in Nordstrom’s end-to-end data and integration program to enable Nordstrom to further improve their merchandise assortment and customer experience. By creating a universal catalog of product, category, sizing data, and imagery, NuORDER helps Nordstrom operate more efficiently at scale by reducing manual processes and accelerating buying cycles. Today, NuORDER collects over 50 data points per item. As Nordstrom develops AI-powered processes to get merchandise to customers more efficiently, NuORDER will increase data capture to support AI-driven forecasting, product recommendations, and personalization. “Collecting comprehensive product data from thousands of brands is time-intensive, costly, and requires extensive collab
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors29.10.2025 11:30:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey Jonas to its Board of Directors, effective immediately. Dr. Jonas brings more than three decades of leadership in pharmaceutical research and development, with a particular focus on neuroscience. As part of this Board transition, Thomas Lönngren will retire from his position on the Board at the end of December after more than six years of service. Mr. Lönngren has been an invaluable counselor across the company’s achievements, including the advancement of the COMP360 program and transition from an early-stage to late-stage clinical company. “With Compass leading the field of psychedelics and looking ahead to potential commercialization for COMP360, we are grateful to have Dr. Jonas’ extensive experience in neuroscience, an area in which he has consistently driven breakthroughs in treatment,” s
Tecnotree Maintains Momentum with Sixth Consecutive Quarter of Profit and Cash Flow29.10.2025 10:12:00 CET | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced today its Q3 2025 results, summarizing financial performance year-to-date ending 30 September 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029815979/en/ Tecnotree Maintains Momentum with Sixth Consecutive Quarter of Profit and Cash Flow Year-to-Date Financial Highlights as of Q3 2025: Positive free cash flow EUR 3.2 (–2.2) million, sixth consecutive quarter of cash-positive operations. Revenue in constant currency EUR 56.6 (54.0) million, +4.8%. EBIT in constant currency EUR 14.9 (13.0) million, +15.0%. Annual recurring revenue EUR 25.1 (23.2) million, +8%. Order backlog EUR 105.5 (75.1) million, +40%. Commenting on the results for the third quarter of 2025, Padma Ravichander, CEO of Tecnotree, says: “Tecnotree’s Q3 2025 results reflect our disciplined focus on profitable order book execution, with year-to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom